Isolation of influenza A(H3N2) virus with 'O' → 'D' phase variation

Research in Virology

Volumn 148, Issue 6, 1997, Pages 427-431

  Ciappi, S ^a   Azzi, A ^a   Stein, C A ^b   De Santis, R ^a   Oxford, J S ^b  

^a UNIVERSITY OF FLORENCE   (Italy)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

'O' 'D' phase; Haemagglutinin; Influenza virus; Nucleotide sequencing; PCR

Indexed keywords

AMINO ACID SUBSTITUTION; ANIMAL CELL; ARTICLE; CELL STRAIN; CHICKEN; CONTROLLED STUDY; GUINEA PIG; INFLUENZA VIRUS A; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; TURKEY (BIRD); VIRUS HEMAGGLUTINATION; VIRUS ISOLATION; VIRUS STRAIN; AMINO ACID SEQUENCE; ANTIGENIC VARIATION; COMPARATIVE STUDY; GENETICS; HUMAN; INFLUENZA VIRUS A H3N2; ISOLATION AND PURIFICATION; METHODOLOGY; MOLECULAR GENETICS; POLYMERASE CHAIN REACTION;

ANIMALIA; AVES; CAVIA PORCELLUS; GALLUS GALLUS; INFLUENZA A VIRUS; INFLUENZA VIRUS; MELEAGRIS GALLOPAVO; RNA VIRUSES; SUS SCROFA;

AMINO ACID SEQUENCE; ANTIGENIC VARIATION; HUMANS; INFLUENZA A VIRUS; INFLUENZA A VIRUS, H3N2 SUBTYPE; MOLECULAR SEQUENCE DATA; POLYMERASE CHAIN REACTION;

EID: 0031283206     PISSN: 09232516     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0923-2516(97)83632-1     Document Type: Article

References (16)

1. 1) viruses in the "O" or "D" phases exhibit biological and antigenic differences. Epidemiol Infect., 111, 135-142.
2. Burnet, F.M. & Bull, D.R. (1943), Changes in influenza virus associated with adaptation to passage in chick embryos. Aust. J. Exp. Biol. Med. Sci., 21, 55-69.
3. Daniels, R.S., Jeffries, S., Yates, P., Schild, G.C., Rogers, G.N., Paulson, J.C., Wharton, S.A., Douglas, A.R., Skehel, J.J. & Wiley, D.C. (1987), The receptor binding and membrane-fusion properties of influenza virus variants selected using anti-hemagglutinin monoclonal antibodies. EMBO J., 6, 1459-1465.
4. Gunther, I., Glatthaar, B., Doller, G. & Garten, W. (1993), An H1 hemagglutinin of a human influenza A virus with a carbohydrate-modulated receptor binding site and an unsual cleavage site. Virus Res., 2, 147-160.
5. 2 influenza virus from an individual. Virology, 165, 446-456.
6. Kwok, S. & Higuchi, R. (1989), Avoiding false positive with PCR. Nature (Lond.), 339, 237-238.
7. Matrosovich, M.N., Gambaryan, A.S. & Chumakov, M.P. (1992), Influenza viruses differ in recognition of 4-O-acetyl substitution of sialic acid receptor determinant. Virology, 188, 854-858.
8. Matrosovich, M.N., Gambaryan, A.S., Tuzikov, A.B., Byramova, N.E., Mochalova, L.V., Golbraikh, A.A., Shenderovich, M.D., Finne, J. & Bovin, N.V. (1993), Probing of the receptor-binding sites of the H1 and H3 influenza A and influenza B virus hemagglutinins by synthetic and natural sialosides. Virology, 196, 111-121.
9. 1) virus. Virology, 160, 31-37.
10. Robertson, J.S., Naeve, C.W., Webster, R.G., Bootman, J.S., Newman, R. & Schild, G.C. (1985), Alterations in the hemagglutinin associated with adaptation of influenza B virus to growth in eggs. Virology, 143, 166-174.
11. Rogers, G.N. & Paulson, J.C. (1983), Receptor determinants of human and animal influenza virus isolates : differences in receptor specificity of the H3 hemagglutinin base on species of origin. Virology, 127, 361-373.
12. Rogers, G.N., Paulson, J.C., Daniels, R.S., Skehel, J.J., Wilson, I.A. & Wiley, D.C. (1983), Single amino acid substitution in influenza hemagglutinin change receptor binding specificity. Nature (Lond.), 304, 76-78.
13. Schild, G.C., Oxford, J.S., De Jong, J.C. & Webster, R.G. (1983), Evidence for host-cell selection of influenza virus antigenic variant. Nature (Lond.), 303, 706-709.
14. Weis, W., Brown, J.H., Cusack, S., Paulson, J.C., Skehel, J.J. & Wiley, D.C. (1988), Structure of the influenza virus haemagglutinatinin complexed with its receptor, sialic acid. Nature (Lond.), 333, 426-431.
15. Wilson, I.A., Skehel, J.J. & Wiley, D.C. (1981), Structure of hemagglutinin membrane glycoprotein of influenza virus at 3Å resolution. Nature (Lond.), 289, 366-373.
16. Zuckerman, P.A., Levantis, P. & Oxford, J.S. (1993), Direct sequence determination of the influenza B HA-1 gene after PCR amplification of clinical specimens from an infected volunteer. J. Virol. Methods, 44, 35-44.